Immune Response of Healthy Subjects Who Received Neonatal Vaccination Course With Engerix™-B Vaccine.
Clinical trial NCT00774995 · COMPLETED
Trial details
- NCT number
- NCT00774995
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2008-11-01
- Primary completion
- 2010-06-01
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.